Contact Us

Allergic rhinitis is a common nasal condition characterized by nasal pruritus, sneezing, rhinorrhea, and nasal congestion. Other symptoms of the condition include, pressure, exaggerated pain responses (hyperalgesia), pain (allodynia), and hyposmia.

The global allergic rhinitis treatment market is estimated to account for US$ 13,950.7 Mn in terms of value and is expected to reach US$ 17,863.6 Mn by the end of 2027.

Global Allergic Rhinitis Treatment Market: Drivers

Increasing prevalence of allergic rhinitis is expected to propel growth of the global allergic rhinitis treatment market over the forecast period. For instance, according to the Centers for Disease Control and Prevention, the U.S. recorded 19.2 million and 5.2 million cases of hay fever in adults aged 18 and over and children under age 18 years, respectively, in 2018.

Moreover, increasing rate of self-medication among patients and availability of over-the-counter (OTC) drugs is also expected to boost demand for allergic rhinitis treatment.

Statistics:

Oral route of administration held dominant position in the global allergic rhinitis treatment market in 2019, accounting for 48.4% share in terms of value, followed by Nasal and Intravenous, respectively.

Figure 1. Global Allergic Rhinitis Treatment Market Share (%), by Value, by Treatment Type, 2019

Allergic Rhinitis Treatment  | Coherent Market Insights

Global Allergic Rhinitis Treatment Market: Restraints

Absence of cure is expected to hinder growth of the global allergic rhinitis treatment market. There is no cure for allergic rhinitis. However, the effects of the condition can be lessened with the use of nasal sprays and antihistamine medications.

Moreover, the symptoms of allergic rhinitis may resemble other conditions or medical problems, which is expected to limit the market growth.

request-sample

Allergic Rhinitis Treatment Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 13,450.3 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 3.6% 2027 Value Projection: US$ 17,863.6 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, Central Africa
Segments covered:
  • By Treatment Type:
    • Immunotherapy: SCIT, SLITD, SLITT.
    • Anti-histamines, Decongestants, Leukotriene Receptor Antagonists, Corticosteroids.
  • By Route of Administration: Oral, Nasal, Intraocular, Intravenous.
  • By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-commerce.
Companies covered:

Merck & Co., Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline PLC, Sanofi S.A., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Alcon (Novartis AG), Unichem Laboratories, Mylan, ALK, Innovus Pharmaceuticals, Inc., and Glenmark Pharmaceuticals Ltd

Growth Drivers:
  • Increasing prevalence of allergic rhinitis
  • Number of treatment options
Restraints & Challenges:
  • Absence of disease curing treatment
  • Similarity of symptoms with other diseases

Global Allergic Rhinitis Treatment Market: Opportunities 

High incidence of asthma is expected to offer lucrative growth opportunities for players in the global allergic rhinitis treatment market. For instance, according to The Global Asthma Report 2018, around 300 million people have asthma worldwide, and the number is expected to reach 100 million by 2025.

Moreover, R&D in allergic rhinitis is also expected to aid in growth of the market. For instance, in May 2019, Glenmark Pharmaceuticals announced positive results from a Phase 3 study of Ryaltris, an investigational fixed-dose combination nasal spray for the treatment of seasonal allergic rhinitis.

The global allergic rhinitis treatment market was valued at US$ 13,450.3 Mn in 2019 and is forecast to reach a value of US$ 17,863.6 Mn by 2027 at a CAGR of 3.6% between 2020 and 2027.

Figure 2. Global Allergic Rhinitis Treatment Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Allergic Rhinitis Treatment  | Coherent Market Insights

Market Trends/Key Takeaways

The market is witnessing R&D of new drugs for improving quality of sleep for allergic rhinitis patients. For instance, in February 2019, ALK released new analysis of clinical trial data showing that its sublingual allergy immunotherapy tablet for the treatment of house dust mite (HDM)-related allergy can significantly improve quality of sleep for allergic rhinitis patients.

Major players in the market are focused on adopting partnership strategies to enhance their market share. For instance, in February 2020, Glenmark Specialty S.A., the Switzerland-based subsidiary of Glenmark Pharmaceuticals Ltd. entered into an exclusive licensing agreement with Hikma Pharmaceuticals PLC for commercializing its novel nasal spray Ryaltris for the treatment of allergic rhinitis in the US.

Global Allergic Rhinitis Treatment Market: Competitive Landscape

Major players operating in the global allergic rhinitis treatment market include, Merck & Co., Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline PLC, Sanofi S.A., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Alcon (Novartis AG), Unichem Laboratories, Mylan, ALK, Innovus Pharmaceuticals, Inc., and Glenmark Pharmaceuticals Ltd.

Global Allergic Rhinitis Treatment Market: Key Developments

Major players in the market are focused on approval and launch of new drugs to expand their product portfolio. For instance, in June 2019, ALK completed the marketing authorization procedure for its tree sublingual allergy immunotherapy tablet ITULAZAX in 17 European countries.

Similarly, in November 2018, Mylan launched Dymista, a new class of treatment for allergic rhinitis in Malaysia.

Allergic rhinitis or hay fever is an IgE-mediated disorder caused by allergens such as mold or tress, animal, dander, house dust mites, weed pollens, and grass. It can occur in two different forms namely, seasonal and perennial, which in turn causes mild or moderate to severe inflammation inside the nose. Some of the major symptoms of allergic rhinitis include nasal congestion, rhinorrhea, sneezing, nasal itching, and itchy eyes, or it can be associated with asthma as well. Allergic rhinitis and sinusitis are linked to each other, as allergic rhinitis blocks the nose, which in turn blocks the sinuses. In 2015, according to World Allergy Organization, over 400 million people suffered from allergic rhinitis worldwide. Moreover, in the U.S., 10-30% adults and around 40% children were affected by allergic rhinitis.

Restraints of the Global Allergic Rhinitis Treatment Market

Major factors hampering the growth of the allergic rhinitis treatment market during the forecast period constitutes of absence of disease curing treatment, and similarity of symptoms with other diseases.

Key features of the study:

  • This report provides in-depth analysis of the global allergic rhinitis treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global allergic rhinitis treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Merck & Co., Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline PLC, Sanofi S.A., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Alcon (Novartis AG), Unichem Laboratories, Mylan, ALK, Innovus Pharmaceuticals, Inc., and Glenmark Pharmaceuticals Ltd.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global allergic rhinitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Allergic Rhinitis Treatment Market, By Treatment Type:
    • Immunotherapy
      • SCIT
      • SLITD
      • SLITT
    • Anti-histamines
    • Decongestants
    • Leukotriene Receptor Antagonists
    • Corticosteroids
  • Global Allergic Rhinitis Treatment Market, By Route of Administration:
    • Oral
    • Nasal
    • Intraocular
    • Intravenous
  • Global Allergic Rhinitis Treatment Market, By Distribution Channel:
    • Retail Pharmacies
    • Hospital Pharmacies
    • E-commerce
  • Global Allergic Rhinitis Treatment Market, By Geography:
    • North America
      • By Treatment Type
        • Immunotherapy
        • SCIT
        • SLITD
        • SLITT
        • Anti-histamines
        • Decongestants
        • Leukotriene Receptor Antagonists
        • Corticosteroids
      • By Route of Administration
        • Oral
        • Nasal
        • Intraocular
        • Intravenous
      • By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • E-commerce
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Treatment Type
        • Immunotherapy
        • SCIT
        • SLITD
        • SLITT
        • Anti-histamines
        • Decongestants
        • Leukotriene Receptor Antagonists
        • Corticosteroids
      • By Route of Administration
        • Oral
        • Nasal
        • Intraocular
        • Intravenous
      • By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • E-commerce
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Treatment Type
        • Immunotherapy
        • SCIT
        • SLITD
        • SLITT
        • Anti-histamines
        • Decongestants
        • Leukotriene Receptor Antagonists
        • Corticosteroids
      • By Route of Administration
        • Oral
        • Nasal
        • Intraocular
        • Intravenous
      • By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • E-commerce
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Treatment Type
        • Immunotherapy
        • SCIT
        • SLITD
        • SLITT
        • Anti-histamines
        • Decongestants
        • Leukotriene Receptor Antagonists
        • Corticosteroids
      • By Route of Administration
        • Oral
        • Nasal
        • Intraocular
        • Intravenous
      • By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • E-commerce
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Treatment Type
        • Immunotherapy
        • SCIT
        • SLITD
        • SLITT
        • Anti-histamines
        • Decongestants
        • Leukotriene Receptor Antagonists
        • Corticosteroids
      • By Route of Administration
        • Oral
        • Nasal
        • Intraocular
        • Intravenous
      • By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • E-commerce
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Treatment Type
        • Immunotherapy
        • SCIT
        • SLITD
        • SLITT
        • Anti-histamines
        • Decongestants
        • Leukotriene Receptor Antagonists
        • Corticosteroids
      • By Route of Administration
        • Oral
        • Nasal
        • Intraocular
        • Intravenous
      • By Distribution Channel
        • Retail Pharmacies
        • Hospital Pharmacies
        • E-commerce
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Merck & Co., Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Boehringer Ingelheim
    • AstraZeneca Plc
    • GlaxoSmithKline PLC
    • Sanofi S.A.
    • Johnson & Johnson
    • Teva Pharmaceutical Industries Ltd.
    • Alcon (Novartis AG)
    • Unichem Laboratories
    • Mylan
    • Innovus Pharmaceuticals, Inc.
    • Glenmark Pharmaceuticals Ltd.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Treatment Type
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
    • COVID-19 Impact Analysis
  4. Global Allergic Rhinitis Treatment Market, By Treatment Type, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Immunotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
        • SCIT
        • SLITD
        • SLITT
    • Anti-histamines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Decongestants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Leukotriene Receptor Antagonists
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Allergic Rhinitis Treatment Market, By Route of Administration, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Nasal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Intraocular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Intravenous
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • E-Commerce
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Allergic Rhinitis Treatment Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Company Profiles
      • Merck & Co., Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Boehringer Ingelheim
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • AstraZeneca
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GlaxoSmithKline PLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Alcon (Novartis AG)
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Unichem Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Mylan Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Innovus Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Glenmark Pharmaceuticals Ltd
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 26 figures on “Allergic Rhinitis Treatment Market – Global forecast to 2027.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users